Microsoft inks healthcare AI deal with Harvard to cut OpenAI reliance- WSJ

Published 09/10/2025, 01:50
© Reuters.

Investing.com-- Microsoft Corporation (NASDAQ:MSFT) is collaborating with Harvard to improve health content in its Copilot AI assistant, as part of a broader push to wean itself off OpenAI, the Wall Street Journal reported on Wednesday. 

CoPilot will begin using Harvard Health Publishing information for healthcare queries with an update scheduled for later in October, the WSJ report said, citing people familiar with the matter. 

Microsoft will pay Harvard a licensing fee. 

Microsoft AI vice president of health Dominic King told the WSJ that the company’s aim is for Copilot to serve answers that are more in line with information from a medical practitioner than anything currently on offer. 

A push into healthcare is also Microsoft’s attempt to carve out its own niche in the highly competitive AI industry. Earlier this year, Microsoft AI said an AI tool it developed was able to diagnose diseases at a rate four times more accurate than a group of doctors, and at a fraction of the cost. 

Microsoft is also attempting to reduce its reliance on OpenAI for AI technology. While the two reached a tentative agreement to extend their partnership earlier this year, reports showed Microsoft was working rapidly on gaining technological independence from OpenAI. 

Microsoft said in August it was testing a homegrown AI model which could eventually be used in Copilot. The company also uses non-OpenAI models, such as rival Anthropic’s Claude, in some of its products. 

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.